The Viresolve® Barrier filter offers opportunities for efficient processing of cell culture media components to reduce the risk of bioreactor contamination.
In this webinar, you will learn the risks of implementing next generation processing, manufacturing planning with regulatory lot definition, and viral safety with new adsorption, filtration, and inactivation steps.
Millipore offers a broad range of single-use equipment, custom designed with our experts to meet the challenging needs of ADC production.
This webinar highlights critical aspects relating to synthetic lipids as raw materials for lipidic formulations, strategies to minimize risk when choosing these, as well as insights into tailored manufacturing and lipids with optimized properties.
In this webinar, you will learn about demonstrating the process development and scale-up of a recombinant CHOZN® GS clone in EX-CELL® Advanced™ cell culture media from small-scale up to 50 L pilot scale.
In taking a more strategic view toward monoclonal antibody manufacturing, there is a drive to develop processes with higher productivity and improved economics without sacrificing robustness or quality.
In our on-demand webinar you can learn how you could emulate Bayer’s success, and how they are continuing to use E-WorkBook to improve lab practices, increase laboratory efficiency and build a laboratory environment suited for business needs both now and in the future.
Explore an approach to interpret the extractables data generated for single-use components used in biopharmaceutical processes by adopting the BPOG (BioPhorum Operations Group) protocol as a baseline testing strategy.
A new single-use (per batch) chromatography platform employs traditional, proven chemistries in an inventive hydrogel polymer membrane format that enables the next generation bioprocessing paradigm.
A webinar to learn about challenges faced with traditional expression systems and how a CHO cell line with the glutamine synthetase knock-out via ZFN provides benefits for fast, efficient cell line development with stable and high titer expression.
|
|
|
|
|
|
|
|
|